You just read:

Immune Therapeutics Announces Filing Acceptance of New Drug Applications for Lodonal™ for the Treatment of Patients with Human Immuno-Deficiency, Cancer and as an Immune Booster

News provided by

Immune Therapeutics, Inc.

26 Oct, 2016, 08:05 ET